News & Updates
Filter by Specialty:
Parkinson’s, T2D drug affords cardioprotection in youth with T1D
31 Dec 2022
byJairia Dela Cruz
Bromocriptine quick release, a medication used for Parkinson’s disease and type 2 diabetes (T2D), appears to confer cardiovascular benefits such as lower blood pressure (BP) and reduced aortic stiffness in teenagers with type 1 diabetes (T1D), according to data from the BCQR-T1D study.
Parkinson’s, T2D drug affords cardioprotection in youth with T1D
31 Dec 2022Semaglutide triumphs as an anti-obesity treatment for adolescents
30 Dec 2022
byRoshini Claire Anthony
Adding a once-weekly dose of semaglutide to lifestyle intervention successfully reduced body mass index (BMI) in adolescents with obesity, according to results of the phase IIIa STEP TEENS trial.